In the medical field, the introduction of AI technology continues to expand for rapid and accurate analysis of medical image data, such as CT and MRI. MEDICALIP developed MEDIP PRO based on AI medical image analysis and segmentation technology. Last year, MEDICALIP completed certification process, such as the Ministry of Food and Drug Safety (MFDS), FDA, and CE approval, for the first among domestic AI medical imaging companies.
MEDIP PRO is an AI software that not only visualizes two-dimensional medical images in three dimensions but also enables segmentation for each organ region faster and more accurately than humans. It dramatically shortens the labeling process, which used to take several days even if the hospital's skilled workers manually divide it. Therefore, utilizing MEDIP PRO can greatly improve the work efficiency of companies, hospitals, and medical staff.
Data processing and analysis capabilities were also verified through requests and cooperation from several medical institutions. Currently, MEDICALIP has been collaborating with leading domestic hospitals including Seoul National University Hospital, Severance Hospital, Samsung Hospital, and Boramae Hospital. Since last year, only the medical image data that has been precisely labeled in-house has reached 1TB. In addition, by fusion of AI technology and the sophistication of experts, MEDICALIP makes it possible to perform detailed labeling even on high-level X-ray, CT, and MRI images.
